Targeting PI3K/Akt signal transduction for cancer therapy

Y He, MM Sun, GG Zhang, J Yang, KS Chen… - Signal transduction and …, 2021 - nature.com
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays a crucial role in various
cellular processes and is aberrantly activated in cancers, contributing to the occurrence and …

[HTML][HTML] Small molecule inhibitors of the ERK signalling pathway: towards novel anti-cancer therapeutics

JL Yap, S Worlikar, AD MacKerell Jr, P Shapiro… - …, 2011 - ncbi.nlm.nih.gov
The Ras→ Raf→ MEK (mitogen-activated kinase kinase)→ ERK (extracellular-
signalregulated kinase) signalling pathway is one of at least five mitogen-activated protein …

The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor

JK Won, HW Yang, SY Shin, JH Lee… - Journal of molecular …, 2012 - academic.oup.com
MEK inhibitor has been highlighted as a promising anti-tumor drug but its effect has been
reported as varying over a wide range depending on patho-physiological conditions. In this …

The importance of being PI3K in the RAS signaling network

C Cuesta, C Arévalo-Alameda, E Castellano - Genes, 2021 - mdpi.com
Ras proteins are essential mediators of a multitude of cellular processes, and its
deregulation is frequently associated with cancer appearance, progression, and metastasis …

The MAPK pathway across different malignancies: a new perspective

M Burotto, VL Chiou, JM Lee, EC Kohn - Cancer, 2014 - Wiley Online Library
The mitogen‐activated protein kinase/extracellular signal‐regulated (MAPK/ERK) pathway
is activated by upstream genomic events and/or activation of multiple signaling events in …

Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview

ES Ali, S Akter, S Ramproshad, B Mondal… - Cancer cell …, 2022 - Springer
MAPK (mitogen-activated protein kinase) or ERK (extracellular-signal-regulated kinase)
pathway is an important link in the transition from extracellular signals to intracellular …

Targeting extracellular signal-regulated protein kinase 1/2 (ERK1/2) in cancer: an update on pharmacological small-molecule inhibitors

L Fu, S Chen, G He, Y Chen, B Liu - Journal of Medicinal …, 2022 - ACS Publications
Extracellular signal-regulated protein kinase 1/2 (ERK1/2), the only known substrate of
MEK1/2, is located downstream of the RAS-RAF-MEK-ERK (MAPK) pathway and is …

Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy

R Mandal, S Becker, K Strebhardt - Oncogene, 2016 - nature.com
Abstract The RAS-RAF-MEK1/2-ERK1/2 pathway is a key signal transduction pathway in the
cells. Critically, it remains constitutively active in approximately 30% of human cancers …

[HTML][HTML] ERK implication in cell cycle regulation

JC Chambard, R Lefloch, J Pouysségur… - … et Biophysica Acta (BBA …, 2007 - Elsevier
The Ras/Raf/MEK/ERK signaling cascade that integrates an extreme variety of extracellular
stimuli into key biological responses controlling cell proliferation, differentiation or death is …

Development of anticancer drugs targeting the MAP kinase pathway

JS Sebolt-Leopold - Oncogene, 2000 - nature.com
Since the discovery of the role of ras oncogenes in tumorigenesis, we have witnessed an
explosion of research in the signal transduction area. In the quest to understand how Ras …